Total Payments
$16,925
2024 Payments
$4,487
Companies
34
Transactions
702
Medicare Patients
655
Medicare Billing
$134,047
Payment Breakdown by Category
Food & Beverage$14,218 (84.0%)
Other$2,625 (15.5%)
Education$82.06 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,218 | 694 | 84.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,625 | 2 | 15.5% |
| Education | $82.06 | 6 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,460 | 147 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,453 | 55 | $0 (2024) |
| Alkermes, Inc. | $1,258 | 57 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,101 | 84 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $999.73 | 48 | $0 (2024) |
| ITI, Inc. | $675.69 | 23 | $0 (2023) |
| Corium, LLC | $605.55 | 22 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $605.00 | 30 | $0 (2024) |
| Lundbeck LLC | $521.60 | 36 | $0 (2024) |
| Indivior Inc. | $506.45 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,487 | 190 | ABBVIE INC. ($891.35) |
| 2023 | $3,011 | 150 | AbbVie Inc. ($807.94) |
| 2022 | $6,090 | 183 | ABBVIE INC. ($3,180) |
| 2021 | $1,893 | 105 | AbbVie Inc. ($580.25) |
| 2020 | $482.42 | 32 | Allergan, Inc. ($170.32) |
| 2019 | $861.34 | 36 | Allergan Inc. ($231.89) |
| 2018 | $99.59 | 6 | Neuronetics, Inc. ($45.40) |
All Payment Transactions
702 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.14 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $29.25 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Neuroscience | ||||||
| 12/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.19 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Central Nervous System | ||||||
| 11/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.43 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: ADHD | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: Central Nervous System | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: CNS | ||||||
| 11/11/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $28.26 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 167 | 504 | $93,150 | $38,551 |
| 2022 | 3 | 159 | 436 | $85,600 | $36,307 |
| 2021 | 4 | 176 | 473 | $81,885 | $35,922 |
| 2020 | 6 | 153 | 310 | $60,875 | $23,267 |
Total Patients
655
Total Services
1,723
Medicare Billing
$134,047
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 281 | $56,200 | $25,237 | 44.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 72 | 209 | $31,350 | $11,251 | 35.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 14 | 14 | $5,600 | $2,063 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 289 | $57,800 | $26,490 | 45.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 59 | 124 | $18,600 | $6,526 | 35.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 23 | 23 | $9,200 | $3,291 | 35.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 223 | $44,625 | $21,444 | 48.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 48 | 144 | $21,600 | $8,100 | 37.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 38 | 39 | $13,650 | $6,137 | 45.0% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 33 | 67 | $2,010 | $240.70 | 12.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 36 | 117 | $23,400 | $8,715 | 37.2% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 32 | 90 | $13,500 | $5,065 | 37.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 28 | 28 | $9,580 | $4,477 | 46.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 25 | 25 | $8,750 | $2,810 | 32.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 21 | 35 | $5,195 | $2,135 | 41.1% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 11 | 15 | $450.00 | $64.50 | 14.3% |
About Dr. Edward Barias, MD
Dr. Edward Barias, MD is a Addiction Psychiatry healthcare provider based in Jupiter, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2013. The National Provider Identifier (NPI) number assigned to this provider is 1689007700.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Barias, MD has received a total of $16,925 in payments from pharmaceutical and medical device companies, with $4,487 received in 2024. These payments were reported across 702 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($14,218).
As a Medicare-enrolled provider, Barias has provided services to 655 Medicare beneficiaries, totaling 1,723 services with total Medicare billing of $134,047. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction Psychiatry
- Location Jupiter, FL
- Active Since 08/13/2013
- Last Updated 07/05/2018
- Taxonomy Code 2084P0802X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689007700
Products in Payments
- VRAYLAR (Drug) $5,862
- CAPLYTA (Drug) $1,152
- REXULTI (Drug) $1,054
- TRINTELLIX (Drug) $975.23
- SPRAVATO (Drug) $652.38
- ABILIFY MAINTENA (Drug) $627.68
- Azstarys (Drug) $550.86
- SUBLOCADE (Drug) $506.45
- VIVITROL (Drug) $470.69
- INGREZZA (Drug) $454.10
- LATUDA (Drug) $382.67
- INVEGA SUSTENNA (Drug) $347.35
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $334.81
- AUSTEDO (Drug) $322.13
- LYBALVI (Drug) $316.01
- ARISTADA (Drug) $305.63
- BRINTELLIX (Drug) $279.56
- QUVIVIQ (Drug) $198.12
- APLENZIN (Drug) $175.72
- UZEDY (Drug) $165.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.